Gonorrhoea: Test of cure for sensitive bacteria? Use of genotyping to disprove treatment failure [6]

International Journal of STD and AIDS

Volumn 15, Issue 3, 2004, Pages 212-

  Komolafe, A J ^a   Sugunendran, H ^a   Corkill, J E ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ANTIBIOTIC RESISTANCE; DRUG SURVEILLANCE PROGRAM; GENOTYPE; GONORRHEA; HUMAN; LABORATORY TEST; LETTER; OPA TYPING; PRIORITY JOURNAL; REINFECTION; TEST OF CURE; TREATMENT FAILURE; UNITED KINGDOM;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENOTYPE; GONORRHEA; HUMANS; NEISSERIA GONORRHOEAE; TREATMENT FAILURE;

EID: 12144287082     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646204322916759     Document Type: Letter

References (2)

1. Holland TM, Hussey J, Pattman RS, Sankar KN, Faldon CM. Audit of gonorrhoea test of cure at Genitourinary Medicine Department in Newcastle upon Tyne, UK. Int J STD AIDS 2003;14:630-2
2. Corkill JE, Komolafe AJ, Neal TJ, et al. Molecular epidemiology of endemic ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool. Int J STD AIDS 2003;14:379-85